Discover
GRCE
Grace Therapeutics, Inc.
2.11
2 x 2.10
1 x 2.12
bid
ask
+
0.00
0.00%
12:33 PM
timesize
| Ytd | -39.02% | |
| 1y | -31.94% |
2.10
day range
2.13
1.79
52 week range
5.18
| Open | 2.10 | Prev Close | 2.11 | Low | 2.10 | High | 2.13 | Mkt Cap | 34.34M |
| Vol | 35.64K | Avg Vol | 275.00K | EPS | -0.57 | P/E | -3.70 | Forward P/E | -2.90 |
| Beta | 0.39 | Short Ratio | 3.25 | Inst. Own | 21.39% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 06-20 | 50-d Avg | 2.33 | 200-d Avg | 3.17 | 1yr Est | 10.44 |
| Income Statement | |||
| Operating Expenses | 3.01M | ||
| Research and Development Expense | 420.00K | ||
| Selling, General and Administrative Expense | 2.59M | ||
| Operating Income | -3.01M | ||
| Income Tax Expense | -1.70M | ||
| Net Income | -1.18M | ||
| Net Income Common Stock | -1.18M | ||
| Net Income Common Stock (USD) | -1.18M | ||
| Consolidated Income | -1.18M | ||
| Earnings per Basic Share | -0.06 | ||
| Earnings per Basic Share (USD) | -0.06 | ||
| Earnings per Diluted Share | -0.06 | ||
| Earning Before Interest & Taxes (EBIT) | -2.88M | ||
| Earning Before Interest & Taxes (USD) | -2.88M | ||
| Weighted Average Shares | 17.26M | ||
| Weighted Average Shares Diluted | 17.26M | ||
| Balance Sheet | |||
| Cash and Equivalents | 16.98M | ||
| Cash and Equivalents (USD) | 16.98M | ||
| Trade and Non-Trade Receivables | 20.00K | ||
| Current Assets | 17.38M | ||
| Property, Plant & Equipment Net | 8.00K | ||
| Total Assets | 66.65M | ||
| Current Liabilities | 2.15M | ||
| Total Liabilities | 2.76M | ||
| Accumulated Retained Earnings (Deficit) | -228.48M | ||
| Accumulated Other Comprehensive Income | -6.04M | ||
| Shareholders Equity | 63.90M | ||
| Shareholders Equity (USD) | 63.90M | ||
| Assets Non-Current | 49.27M | ||
| Goodwill and Intangible Assets | 49.27M | ||
| Liabilities Non-Current | 612.00K | ||
| Trade and Non-Trade Payables | 2.15M | ||
| Tax Liabilities | 612.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 2.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.69M | ||
| Net Cash Flow from Operations | -1.69M | ||
| Share Based Compensation | 182.00K | ||